HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)].

AuthorsR Zittoun, B Rio, A Delmer, A Vekhof, F Mandelli, R Willemze, T de Witte, S Tura, P R Ferrini, P Stryckmans
JournalNouvelle revue francaise d'hematologie (Nouv Rev Fr Hematol (1978)) Vol. 35 Issue 1 Pg. 15-6 (Feb 1993) Germany
Vernacular TitleComparaison des consolidations intensives par autogreffe de moelle ou par chimiothérapie des leucémies aigues myéloblastiques en première rémission complète: protocole AML8A du Leukemia Cooperative Group de l'Organisation Européenne de Recherche et Traitements du Cancer (EORTC).
PMID8511034 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Amsacrine
  • Cytarabine
  • Daunorubicin
Topics
  • Actuarial Analysis
  • Amsacrine (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bone Marrow Transplantation
  • Combined Modality Therapy
  • Cytarabine (administration & dosage)
  • Daunorubicin (administration & dosage)
  • Humans
  • Leukemia, Myeloid, Acute (therapy)
  • Remission Induction
  • Survival Analysis
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: